Docetaxel and cisplatin in patients with advanced gastric cancer: results of Japanese phase I/II study

被引：1
|
作者：
Soh Saitoh
Yuh Sakata
机构：
[1] Aomori Prefectural Central Hospital,
[2] Misawa Municipal Hospital,undefined
来源：
Gastric Cancer | 2002年 / 5卷 / Suppl 1期
关键词：
Docetaxel; Cisplatin; Gastric cancer;
D O I：
10.1007/s10120-002-0209-0
中图分类号：
学科分类号：
摘要：
Two phase II monotherapy studies of docetaxel in patients with advanced gastric cancer were performed in Japan. In group A, docetaxel showed an overall response rate of 23.7% (14/59) in 59 patients, and the adverse reactions were tolerable. In group B, this agent showed the same response rate, of 23.7% (14/59) and the same adverse reaction profile.
引用
收藏
页码：23 / 26
页数：3
相关论文
共 50 条
  • [21] A phase I/II trial of docetaxel, capecitabine, and cisplatin as a first line chemotherapy for advanced gastric cancer.
    Kang, YK
    Kim, TW
    Chang, HM
    Ryu, MH
    Yook, JH
    Oh, ST
    Kim, BS
    Lee, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 329S - 329S
  • [22] Phase II study of docetaxel, cisplatin and modulated oral tegafur (DCT) in advanced gastric cancer (AGC)
    Pericay, Carles
    Losa, Ferran
    Nogue, Miquel
    Gallardo, Enrique
    Fernandez-Morales, Luis
    Dalmau, Elsa
    Martinez-Peralta, Susana
    Santos-Vivas, Cristina
    Pous, Enric
    Saigi, Eugeni
    ANNALS OF ONCOLOGY, 2006, 17 : 324 - 324
  • [23] Phase I study of paclitaxel and cisplatin for patients with advanced or recurrent gastric cancer
    Nagata, N
    Kobayashi, M
    Kojima, H
    Kondo, K
    Hirabayashi, N
    Matsui, T
    Kataoka, M
    Takiyama, W
    Miyashita, Y
    Nakazato, H
    Araki, A
    Itoh, H
    Nakao, A
    Sakamoto, J
    HEPATO-GASTROENTEROLOGY, 2005, 52 (66) : 1905 - 1910
  • [24] Weekly docetaxel and cisplatin with capecitabine and bevacizumab (AVDCX) in patients with advanced esophagogastric cancer: Results of a phase Ib/II study
    Purim, Ofer
    Kundel, Yulia
    Gonik, Udi Sadeh
    Idelevich, Efraim
    Medalia, Gal
    Gordon, Noa
    Sulkes, Aaron
    Brenner, Baruch
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Final report of Phase I/II study of docetaxel and S-1 for patients with advanced gastric cancer
    Sakata, Y.
    Yamaguchi, K.
    Hyodo, I.
    Koizumi, W.
    Narahara, H.
    Dol, T.
    Komatsu, Y.
    Kato, T.
    Saitoh, S.
    Akiya, T.
    EJC SUPPLEMENTS, 2005, 3 (02): : 213 - 213
  • [26] Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer
    Tatsuya Miyazaki
    Makoto Sohda
    Naritaka Tanaka
    Shigemasa Suzuki
    Keisuke Ieta
    Makoto Sakai
    Akihiko Sano
    Takehiko Yokobori
    Takanori Inose
    Masanobu Nakajima
    Minoru Fukuchi
    Hitoshi Ojima
    Hiroyuki Kato
    Hiroyuki Kuwano
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 449 - 455
  • [27] Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer
    Miyazaki, Tatsuya
    Sohda, Makoto
    Tanaka, Naritaka
    Suzuki, Shigemasa
    Ieta, Keisuke
    Sakai, Makoto
    Sano, Akihiko
    Yokobori, Takehiko
    Inose, Takanori
    Nakajima, Masanobu
    Fukuchi, Minoru
    Ojima, Hitoshi
    Kato, Hiroyuki
    Kuwano, Hiroyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 449 - 455
  • [28] Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer
    Hosokawa, Ayumu
    Ando, Takayuki
    Ogawa, Kohei
    Ueda, Akira
    Yoshita, Hiroki
    Mihara, Hiroshi
    Fujinami, Haruka
    Kajiura, Shinya
    Yabushita, Kazuhisa
    Horikawa, Naoki
    Kobayashi, Yuka
    Yoshioka, Akira
    Origasa, Hideki
    Sugiyama, Toshiro
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (10): : 977 - 981
  • [29] Phase II study of docetaxel (D) as salvage chemotherapy in patients with advanced gastric cancer
    Vanhoefer, U
    Harstrick, A
    Wilke, H
    Achterrath, W
    Preusser, P
    Stahl, M
    Fink, U
    Seeber, S
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S145 - S145
  • [30] A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer
    Y H Park
    B-Y Ryoo
    S-J Choi
    H-T Kim
    British Journal of Cancer, 2004, 90 : 1329 - 1333
12345